Skip to main content
Fanjian Zeng on Muck Rack

Fanjian Zeng

As seen in: Frontiers in Immunology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Fanjian

Contact Fanjian, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

The SAGES scoring model leads to personalized treatment via the combination of TACE, TKIs and ICIs for unresectable hepatocellular carcinoma

|
By Hesheng Lin, Xueyao Wang, Jianhong Zhong, Ning Peng, Shaoping Liu, Wenfeng Li, Ze Su, Junjie Ou, Hongbing Yao, Shuqun Li, Fanjian Zeng, Peisheng Wu
| Frontiers in Immunology
Abstract Background and aims: Transcatheter chemoembolization (TACE) combined with tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) shows promising efficacy in treating unresectable hepatocellular carcinoma (uHCC), but the specific patient population that would benefit most from this regimen remains unclear.
Open in Who Shared Issue with article?
See all 1 articles